Contraception Flashcards
1
Q
CONTRACEPTION IN BREASTFEEDING WOMEN:
A
- > 98% effective if fully breastfeeding(4-6h intervals), amenorrhoeic and within 6/12 post-partum
- Avoic COCP until ≥30d.
- Does not require emergency contraception if UPSI <21d post-partum
2
Q
CONTRACEPTION IN LATER YEARS
A
- If <50y, continue contraception for ≥2y after last period.
- If >50y, continue contraception for ≥1y after last period.
- IUD >40y may not need replacing
- If not sure when menopause reached due to use of Mirena/implant/HRT, stop at 56y
3
Q
MISSED PILL INSTRUCTIONS::
- ≥2 pills(30 mcg)
- 1 pill(30 mcg)
- ≥2 pills(20 mcg)
- > 7 pills missed
- Progesterone-only Pill
a) Norethisterone(Micronor)
b) Desogestrel(Cerazette)
A
- Take most recent pills and continue
- Condoms/abstain for 7d
- Week 1: consider emergency contraception if UPSi during pill-free week/in week 1
- Week 2: No need emergency contraception after taking pills in preceding 7d
- Week 3: Omit pill-free week then start new pack
- Take most recent pills and continue
- Take most recent pill and continue remaining ones
- No additional contraception required - Take most recent pills and continue
- Condoms/abstain for 7d
- Week 1: Consider emergency contraception
- Week 3: Omit pill-free week
- Take most recent pills and continue
- Treat as if stopped using pill.
- a) If pill missed >3h, take another asap and condoms for 2d.
b) Can take within 12h window
4
Q
COCP:
- Mechanism
- Advantages
- Disadvantages:
a) Major side-effects
b) Minor side-effects - Instructions
- 1st year failure rate
A
- contains oestrogen and progestogen
- negative feedback on gonadotrophin release, inhibits ovulation, thins endometrium and thickens cervical mucus
- contains oestrogen and progestogen
- Improved acne and hirsutism; more regular, lighter periods; portects against simple ovarian cysts, benign breast cysts, fibroids, endometriosis; lowers risk of PID, ovarian/endometrial/bowel cancer.
- a) MI, venous thrombosis(3rd generation pill higher risk compared to 2nd gen), cerebrovascular accident, focal migraine, hypertension, jaundice, liver, cervical and breast carcinoma.
b) Breakthrough bleeding in first few months; oestrogenic: nausea, headache, dizziness, breast tenderness, increased vaginal secretions; progestogenic: headache, mood change, breast tenderness, bloating & weight gain, vaginal dryness - Start within first 5d of cycle. If any other time, condoms/abstain for first 7d
- Take daily at same time for 3w then 1w break. Similar uterine bleeding to menstruation.
- Intercourse safe during pill-free interval as long as next pack started on time
- back-to-back regimen can reduce frequency of withdrawal bleed
- Poor absorption when diarrhoea/vomiting/taking oral antibiotics, So follow missed pill instructions for each day of illness. When on antibiotics(now only rifampicin, used to be all antibiotics), continue taking pill but condoms/abstain for 7d after antibiotic course. also increase dose with liver-enzyme inducers
- Start within first 5d of cycle. If any other time, condoms/abstain for first 7d
- 0.2-3%. >99% effective if taken correctly
5
Q
CONTRAINDICATIONS(COCP):
- Absolute
- Relative
A
- Hx of venous thrombosis, cerebrovascular accident, ischaemic heart disease, severe hypertension; Smoker >35y, ≥15 cigarettes/day, migraine with aura; active breast/endometrial cancer; inherited thrombophilia; BMI>40; Active/chronic liver disease; pregnancy; diabetes with vascular complications.
- Smoker; Chronic inflammatory disease; Renal impairment; diabetes; Age >40y; BMI 35-40; Breastfeeding up to 6/12 post-partum
6
Q
OTHER FORMS OF COMBINED HORMONE CONTRACEPTION:
A
- Transdermal patch(Evra)
- Ethinyloestradiol(34 mcg) + norelgestromin
- Patch applied weekly for 3w then patch-free week
- if delay in changing patch <48h, change immediately and no further precautions. If >48h, change immediately and barrier method/abstain for 7d. If delay at end of patch-free week, barrier contraception/abstain for 7d
- same efficacy, side-effects and CI as COCP - Combined vaginal ring(Nuvaring)
- Ethinyloestradiol(15 mcg)+progestogen etonogestrel(120 mcg)
- ring worn for 3w then ring-free week.
- lower systemic oestrogenic side effects
7
Q
PROGESTOGEN-ONLY PILL:
- Mechanism
- Indications
- CI
- Side-effects
- 1st year failure rate
A
- 350 mg norethisterone
- makes cervical mucus hostile to sperm, endometrial changes prevent implantation
- inhibits ovulation in 50% of women; cerazette in >95% of cycles
- 350 mg norethisterone
- Usually in:
- CI to oestrogen
- Older women who smoke
- During breast feeding - Suspected pregnancy, unexplained menstrual upset, active liver disease, Serious cardiovascular disease(till investigated)
- Vaginal spoting, Weight gain, mastalgia, PMS-like symptoms
- 0.3-4%, 0.7-1.1%(Cerazette)
8
Q
DEPO PREPARATIONS:
- Medroxyprogesterone acetate
- Norethisterat
*1st year failure rate: <1%
A
- 150mg every 3/12
- Start within 5d at start of period
- Inhibit ovulation, thicken cervical mucus, thins endometrium
- Potential SE: Irregular bleeding initially, delayed return of fertility upon cessation, weight gain, lowers bone mineral density over 2-3y(reversible upon cessatin)
- useful during lactation and if compliance problem
- 150mg every 3/12
- given every 8w
- short-term interim contraception
- given every 8w
9
Q
NEXPLANON(ETONORGESTREL): 1. Mechanism: 2. Duration: 3. Advantages: 4. Side effects: 5, Contraindications:
A
- Inhibits ovulation and thickens cervical mucus. Additional contraception for first 7d if not inserted on day 1-5 of menstrual cycle
- 3 years
- Rapid return of fertility, no effect on bone metabolism, 1st year failure rate 0-0.07%.
- Irregular bleeding in 1st year, progestogenic effects: headache, nausea, breast pain
- Ischaemic heart disease, stroke, unexplained suspicious vaginal bleeding, past and current breast cancer, severe liver cirrhosis, liver cancer.
- affected by liver enzyme-inducers hence swith to other method or use additional contraception util 28d after stopping treatment
10
Q
EMERGENCY CONTRACEPTION:
- Morning-after pill
- Copper IUD
A
- STI screen and arrange for future contraception
a) Levonelle(Levonorgestrel)
- Inhibit ovulation and implantation
- affects sperm function and endometrial receptivity
- Within 24h: 95% effective
- Within 72h: 84% effective
- SE: Menstrual disturbances in next cycle, vomiting(1%). If vomit within 2h, repeat dose
- Follow-up in 3w if absent periods
- can use >1 time in menstrual cycle
- Start suitable hormonal contraception immediately and condoms/abstain until contraception becomes effective.
b) Ulipristal(ellaOne)
- prevents/delays ovulation and helps reduce implantation
- as effective as ellaOne but can use up to 120h after UPSI
- reduces effectiveness of progesterone-containing contraceptives so condoms/abstain until next period.
- not recommended to use >1 time in same menstrual cycle
- Delay breastfeeding for 1w
- CI in severe asthma and liver disease
- Start hormonal contraception 5d after taking ulipristal then further days for contraception to become effective. Condom/abstain during this period.
- STI screen and arrange for future contraception
- Inserted up to 5d after UPSI/expected ovulation day
- Failure rate <0.1%
- Prophylactic anitbiotics if high-risk of STI
- If infection, no need to remove Cu-IUD. Test and give suitable antibiotic treatment
- Left at least until next period.
- Inserted up to 5d after UPSI/expected ovulation day
11
Q
BARRIER METHODS:
- Condoms
- Female condom
- Diaphragms and caps
- Spermicides
A
- Efficacy: Perfect use: 98%, Typical use: 80% Effectiveness is user-dependent.
* Use water-based lubricants as oil-based lubricants reduce latex integrity.
- Advantages: Protective against STIs
- Efficacy: Perfect use: 98%, Typical use: 80% Effectiveness is user-dependent.
- Efficacy: Perfect use: 95%, Typical use: 80% Also protective against STIs
- Fitted in before intercourse and must remain for ≥6h after intercourse
- cervical caps have failure rate: 5/100 woman years
- protective against PID but less protection against HIV.
- 92-96% effective if used with spermicide - Used in conjunction with barrier methods
12
Q
MIRENA(LEVONORGESTREL-IUD):
- Mechanism:
- 1st year Failure rate
- Insertion
- Advantages:
- Risks:
- Contraindications:
a) Absolute
b) Relative
A
- Endometrial chnges to prevent implantation and Changes cervical mucus to impede sperm migration. Can take up to 7d for contraceptive action
- 0-0.6/100 woman-years
- within 7d of 1st period/any time if no intercourse since last period/within 5d of earliest date of ovulation
- Prior to insertion, pelvic examination, endocervical swabs, ensure sound uterus.
- use aseptic technique.
- Check threads
- change after 5y
- within 7d of 1st period/any time if no intercourse since last period/within 5d of earliest date of ovulation
- Reduces menstrual loss, don’t need to remember to take anything, rapid resumption of fertility upon removal
- Pain during insertion, expulsion(1 in 20) within first 3 months; Irregular bleeding but eventual reduced bleeding/amenorrhoea; Uterine perforation at insertion(<0.5%), increased risk(10%) of PID during first 20d after insertion especially if young and multiple partners, likely ectopic pregnancy if happens
- Inform doctor if: intermenstrual bleeding; pelvic pain/vaginal discharge; feels might be pregnant - a) Endometrial/cervical cancer; Undiagnosed vaginal bleeding; active/recent pelvic infection; current breast cancer; pregnancy
b) Previous ectopic; Immunocompromised including HIV; Young; Multiple partners; Nulliparous
13
Q
COPPER-IUD;
- Mechanism
- Advantage:
- Risks:
A
- Cu ions toxic to sperm and blastocyst; blocks implantation. Imeediate action.
- Lasts up to 8y
- Similar to Mirena, +possible heavier/more painful menstruation
14
Q
FEMALE STERILIZATION:
- Methods:
- Efficacy:
- Risks:
A
- Filshie clips; Transcervical hysteroscopic placement of microinserts(Essure). General anaesthesia
- Failure rate: 1 in 200
- Ectopic pregnancy if pregnant; Operative risk: Visceral damage, inadequate access to tubes; Postoperative: Pain. Reversal possible but not guaranteed with Filshie clips, won’t be NHS-funded.
15
Q
MALE STERILIZATION:
- Method
- Efficacy
- Complications
A
- Local anaesthesia, ligation and removal of small segment of vas deferens
- Confirmed by 2 negative semen analyses, can take up to 6/12
- Local anaesthesia, ligation and removal of small segment of vas deferens
- Failure rate: 1 in 2000
- Failure, post-op haematomas and infection, chronic pain